Neutrophil subtypes: distinct cellular targets for therapeutic intervention

Project Information

TANTUMorNEUVACCINE

Grant agreement ID: 750973

DOI

10.3030/750973

Project closed

EC signature date 4 April 2017

Start date 1 October 2017

End date 30 September 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 265 840,20

EU contribution

€ 265 840,20

Coordinated by

FONDAZIONE PER L'ISTITUTO DI RICERCA IN BIOMEDICINA
Switzerland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy

Author(s): Mauro Di Pilato, Edward Y. Kim, Bruno L. Cadilha, Jasper N. Prüßmann, Mazen N. Nasrallah, Davide Seruggia, Shariq M. Usmani, Sandra Misale, Valentina Zappulli, Esteban Carrizosa, Vinidhra Mani, Matteo Ligorio, Ross D. Warner, Benjamin D. Medoff, Francesco Marangoni, Alexandra-Chloe Villani, Thorsten R. Mempel
Published in: Nature, Issue 570/7759, 2019, Page(s) 112-116, ISSN 0028-0836
Publisher: Nature Publishing Group
DOI: 10.1038/s41586-019-1215-2